reference/4434509

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4434509

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	191
issn	0167-8140
issueIdentifier	2
pageRange	183-191
publicationName	Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
startingPage	183
bibliographicCitation	Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT; Swedish Brain Tumour Study Group. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Radiother Oncol. 2008 Aug;88(2):183–91. doi: 10.1016/j.radonc.2006.04.015. PMID: 18336940.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b9962226f2009b79b461bb71b1e1ddb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_797557eec8ce0546dd04ba83ee714b57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3e9856d9aa388dbf5d43322f42a1873 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_630a088236ed7ede8d581e9b35bddff7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2313d33fda3394888cb549e1126a1927 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f21de5e172cfc1a5f38983fea6cf494 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c96672236b41cfc671f0acc9882b0ff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eeab135753c97cb3111b43adaf43ece9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7a31ffb09c80cae794d89e591663d1c
date	200808
identifier	https://doi.org/10.1016/j.radonc.2006.04.015 https://pubmed.ncbi.nlm.nih.gov/18336940
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6944 https://portal.issn.org/resource/ISSN/0167-8140
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)
discusses	http://id.nlm.nih.gov/mesh/M0016544 http://id.nlm.nih.gov/mesh/M0002831 http://id.nlm.nih.gov/mesh/M0008855 http://id.nlm.nih.gov/mesh/M0002832
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001896Q000008 http://id.nlm.nih.gov/mesh/D010649Q000008 http://id.nlm.nih.gov/mesh/D005909Q000532 http://id.nlm.nih.gov/mesh/D016754Q000379 http://id.nlm.nih.gov/mesh/D001932Q000532
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D001896Q000493 http://id.nlm.nih.gov/mesh/D016754Q000009 http://id.nlm.nih.gov/mesh/D010649Q000493 http://id.nlm.nih.gov/mesh/D005632Q000493 http://id.nlm.nih.gov/mesh/D001895Q000097 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005632Q000008 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918763 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53503 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723872 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150315 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9410

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129122856 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127548128 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128844711 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813

Total number of triples: 64.